Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
Artisan Partners Limited Partnership Grows Stake in Twist Bioscience Corporation $TWST
03:26am, Friday, 27'th Feb 2026
Artisan Partners Limited Partnership boosted its stake in Twist Bioscience Corporation (NASDAQ: TWST) by 26.7% during the third quarter, according to its most recent 13F filing with the Securities and
Twist Bioscience (NASDAQ:TWST) Shares Gap Down – What’s Next?
03:26am, Sunday, 22'nd Feb 2026
Shares of Twist Bioscience Corporation (NASDAQ: TWST - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $52.49, but opened at $49.90. Twist Bioscience shares
Twist Bioscience Corporation (TWST) Shareholder/Analyst Call Transcript
03:54pm, Wednesday, 18'th Feb 2026
Twist Bioscience Corporation (TWST) Shareholder/Analyst Call Transcript
Cathie Wood Bets Big on Semiconductors, Adds Broadcom and AMD
09:49am, Wednesday, 18'th Feb 2026
Cathie Wood's ARK Invest ETFs made notable portfolio moves on Tuesday, according to a Tuesday filing with the SEC.Wood increased exposure to semiconductor firms
Twist Bioscience to Present at Upcoming Investor Conferences
08:00am, Wednesday, 18'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
07:00am, Tuesday, 17'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has entered into a licensing agreement wi
Biotech Beat Nvidia in 2025. Can It Do It Again?
09:51am, Wednesday, 11'th Feb 2026
In this podcast, Motley Fool analysts Karl Thiel, Tom King, and Tim Beyers discuss:
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
08:00am, Tuesday, 10'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit and Twis
Twist Bioscience: Liquid Biopsy And AI Tailwinds
02:53am, Tuesday, 10'th Feb 2026
Twist Bioscience's stock has moved high in recent months, driven by optimism related to AI-enabled drug discovery and MRD testing. Q1 growth was modest, due in large part to an air pocket in demand ca
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results
09:27am, Tuesday, 03'rd Feb 2026
Twist Bioscience Corporation (NASDAQ: TWST) on Monday posted better-than-expected sales for the first quarter.
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:00am, Tuesday, 03'rd Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and
Why Is Twist Bioscience Stock Soaring Monday?
02:27pm, Monday, 02'nd Feb 2026
Twist Bioscience Corporation (NASDAQ: TWST) on Monday posted first-quarter 2026 results of a loss of 50 cents per share, in line with the Wall Street expectations.
Twist Bioscience: Ingenious Product Still Lacks Compelling Use Cases
02:24pm, Monday, 02'nd Feb 2026
Twist Bioscience Corporation reported Q1 2026 revenue of $103.7M, up 17% YoY, and raised full-year guidance to $435–$440M. TWST targets adjusted EBITDA breakeven in Q4 2026, with gross margin expect
Twist Bioscience Surges with Strong Q1 Results and Raised Revenue Guidance
12:14pm, Monday, 02'nd Feb 2026
Twist Bioscience (TWST) saw a significant rise in its stock after reporting impressive first-quarter results for 2026. The synthetic DNA leader achieved a total
Twist Bioscience Corporation (TWST) Q1 2026 Earnings Call Transcript
12:02pm, Monday, 02'nd Feb 2026
Twist Bioscience Corporation (TWST) Q1 2026 Earnings Call Transcript
